Affymetrix representatives recently provided an update on the firm's forthcoming 384-sample genotyping product and advocated its use in both agricultural biotechnology and human disease research.

"The 384 format is ideally suited for genomic selection or marker selection, where you have to do high-throughput [analyses on the order of] 3,000 samples per week," said Shantanu Kaushikkar, head of strategic marketing for agrigenomics at Affy. "It's the next step for ag researchers."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.